2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,
Bay X 1005,
Bay X1005,
Bay-X1005,
BAYX-1005,
DG-031,
Veliflapon,
Veliflapon,
128253-31-6,
Bay-x-1005,
Bay X 1005,
DG-031,
Bayx-1005,
Bay X1005,
UNII-JXH6X663L0,
Bay-X1005,
BAY 1005,
DG 031,
CHEMBL88712,
JXH6X663L0,
2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,
BAY-X 1005,
Benzeneacetic acid, alpha-cyclopentyl-4-(2-quinolinylmethoxy)-, (R)-,
C23H23NO3,
(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid,
Veliflapon [USAN:INN],
Velifapon,
Veliflapon (USAN/INN),
AC1L3X6M,
MLS006010705,
Benzeneacetic acid, a-cyclopentyl-4-(2-quinolinylmethoxy)-,(aR)-,
GTPL5148,
SCHEMBL1004174,
BAY-X-005,
CTK4B5894,
DTXSID60155843,
ZEYYDOLCHFETHQ-JOCHJYFZSA-N,
ZINC598193,
BDBM50052030,
MFCD00870329,
AKOS024457673,
SB19085,
NCGC00250411-01,
SMR004701678,
LS-172700,
BAY-X-1005, >=98% (HPLC),
D06664,
Cyclopentyl-[4-(quinolin-2-ylmethoxy)-phenyl]-acetic acid,
(R)-?-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid,
(R)-Cyclopentyl-[4-(quinolin-2-ylmethoxy)-phenyl]-acetic acid,
2-(R)-cyclopentyl-2-(4-(2-quinolylmethoxy)phenyl)acetic acid,
(r)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid,
alpha-Cyclopentyl-4-(2-quinolinylmethoxy)-(R)-benzeneacetic acid,
(alphaR)-alpha-Cyclopentyl-4-(2-quinolinylmethoxy)-benzeneacetic acid,
Benzeneacetic acid, alpha-cyclopentyl-4-(2-quinolinylmethoxy)-, (alphaR)-,
Veliflapon [USAN],
D0S6VB,
DG031,
C23-H23-N-O3,
CID123723,
C079315,